Piramal Healthcare bought Cipla’s oral contraceptive brand, i-pill, for Rs 95 crore, to achieve its target of trebling its over-the-counter (OTC) drug business in three years. i-pill is an emergency contraceptive brand, that recorded Rs 31 crore sales last year, and competes with Mankind Pharma’s Unwanted 72, in a fast-growing, Rs 100-crore Indian market.
The all-cash acquisition of the brand is part of Piramal’s efforts to grow its OTC drug business in